BPC-157 protected against adaptive cytoprotection involving endogenous (internal) stomach irritants, not just external ones, and maintained protection even when anti-inflammatory drugs blocked prostaglandins.
Works without prostaglandinsBPC-157 maintained stomach protection even when indomethacin blocked prostaglandin synthesis — standard ulcer drugs could not
What the researchers found
BPC-157 maintained cytoprotective activity even when prostaglandin synthesis was blocked by indomethacin, unlike standard anti-ulcer agents, indicating prostaglandin-independent protective mechanisms for adaptive cytoprotection against endogenous irritants.
Why it matters
NSAIDs like ibuprofen and aspirin block prostaglandins, causing stomach ulcers. If BPC-157 protects the stomach through prostaglandin-independent mechanisms, it could prevent NSAID-induced ulcers — a massive clinical need.
How the study worked
Animal study establishing new adaptive cytoprotection models using endogenous stomach irritants. BPC-157 and standard anti-ulcer agents tested with and without indomethacin-induced prostaglandin blockade.
What this study cannot tell us
Complex experimental model in rats. The specific prostaglandin-independent pathways were not identified. Clinical translation of adaptive cytoprotection concepts is challenging.
How to read the evidence
Preliminary animal evidence from an innovative model design demonstrating a unique mechanistic property of BPC-157.
When this study was published
Published in 1999. BPC-157's prostaglandin-independent gastroprotection has been further confirmed and is considered a key differentiating feature.
The bigger picture
Millions take NSAIDs daily, risking stomach ulcers from prostaglandin blockade. A gastroprotective agent that works without prostaglandins could prevent these complications, and BPC-157 appears to have exactly this property.
Questions still open
- Which prostaglandin-independent pathways does BPC-157 activate?
- Could BPC-157 prevent NSAID-induced stomach ulcers in humans?
- Does the prostaglandin-independent mechanism involve the NO pathway?
Common questions
Why is prostaglandin-independent protection important?
Could BPC-157 be taken with NSAIDs?
Read the original research
New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin.
European journal of pharmacology, 364(1), 23-31
Citation
Sikirić, P; Seiwerth, S; Desković, S; Grabarević, Z; Marović, A; Rucman, R; Petek, M; Konjevoda, P; Jadrijević, S; Sosa, T; Perović, D; Aralica, G; Turković, B. (1999). New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin.. European journal of pharmacology, 364(1), 23-31.